Globus Medical (GMED) Long-Term Deferred Tax (2011 - 2026)

Globus Medical's Long-Term Deferred Tax history runs 16 years deep, the most recent figure standing at $214.8 million for Q1 2026.

• Quarterly Long-Term Deferred Tax rose 84.13% year-over-year to $214.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $214.8 million (up 84.13% YoY) and the FY2025 annual result came in at $218.2 million, up 131.65% from the prior year.
• Long-Term Deferred Tax was $214.8 million for Q1 2026 at Globus Medical, down from $218.2 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $275.9 million in Q2 2025 and bottomed at $7.3 million in Q3 2023.
• A 5-year average of $89.2 million and a median of $48.8 million in 2022 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax sank 83.64% — and 2025, when it jumped 1416.0%.
• Globus Medical's Long-Term Deferred Tax stood at $48.8 million in 2022, then sank by 78.12% to $10.7 million in 2023, then surged by 781.61% to $94.2 million in 2024, then soared by 131.65% to $218.2 million in 2025, then declined by 1.56% to $214.8 million in 2026.
• Business Quant data shows GMED's Long-Term Deferred Tax at $214.8 million in Q1 2026, $218.2 million in Q4 2025, and $232.4 million in Q3 2025.